Peanut allergy prognosis up to age 12: Oral food challenge‐based study in Japanese children
Pediatric Allergy and Immunology · 2026-10 · 37 (10)
DOI: 10.1111/pai.70489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 02.10.2026. Verfasst von Kaito Goto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy, Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Kanagawa, Japan. Hauptthemen laut MEDLINE: Peanut Hypersensitivity, Allergens. Die Arbeit nennt 29 Literaturangaben. Gefördert von: St. Marianna University School of Medicine.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The natural history of peanut allergy based on oral food challenge (OFC) outcomes has been rarely reported. We investigated the clinical course of peanut allergy up to 12 years of age using OFC results.
Methods
The participants were children diagnosed with peanut allergy by 3 years of age, defined by peanut sensitization with definitive immediate‐type symptoms or a positive OFC. Stepwise OFCs were performed on separate days with total ingestion amounts of 0.5, 3, and 10 g of peanut. Tolerance was assessed through regular OFCs and defined as a negative result on a 10‐g OFC or the ability to consume ≥10 g of peanut. We retrospectively analyzed OFC outcomes up to 12 years of age.
Results
We included 42 children (81% male) with a median peanut‐specific IgE (sIgE) of 16.8 kU A /L at age 3; 16 children (38%) had a history of anaphylaxis. Overall, 82 OFCs were performed; four children (10%) discontinued follow‐up. Kaplan–Meier–estimated tolerance acquisition rates were 2%, 18%, and 36% at 4, 6, and 12 years of age, respectively. Compared with the non‐tolerant group, the tolerant group had lower peanut‐sIgE at 3 years of age (median: 3.67 vs. 27.6 kU A /L; adjusted HR for log‐transformed value: 0.31, 95% CI: 0.10–0.96, p = .041), and lower peanut‐sIgE at 6 years and Ara h 2‐sIgE at 6 and 9 years of age.
Conclusions
One‐third of Japanese children diagnosed with peanut allergy by 3 years of age achieved tolerance by 12 years of age. Lower peanut‐sIgE levels at 3 years of age were associated with subsequent tolerance acquisition. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Allergy, Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Kanagawa, Japan.
- Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
ORCID-Profile: Kaito Goto, Ken-Ichi Nagakura, Naoko Fusayasu, Kyohei Takahashi, Sakura Sato, Motohiro Ebisawa, Noriyuki Yanagida
Förderung
- St. Marianna University School of Medicine
Zitieren
APA
Goto, K., Nagakura, K. I., Fusayasu, N., Takahashi, K., Sato, S., Ebisawa, M., Shimizu, N., & Yanagida, N. (2026). Peanut allergy prognosis up to age 12: Oral food challenge‐based study in Japanese children. Pediatric Allergy and Immunology, 37(10). https://doi.org/10.1111/pai.70489
Vancouver
Goto K, Nagakura KI, Fusayasu N, Takahashi K, Sato S, Ebisawa M, et al. Peanut allergy prognosis up to age 12: Oral food challenge‐based study in Japanese children. Pediatric Allergy and Immunology. 2026;37(10). doi:10.1111/pai.70489
BibTeX
@article{Goto2026,
author = {Goto, Kaito and Nagakura, Ken-Ichi and Fusayasu, Naoko and Takahashi, Kyohei and Sato, Sakura and Ebisawa, Motohiro and Shimizu, Naoki and Yanagida, Noriyuki},
title = {Peanut allergy prognosis up to age 12: Oral food challenge‐based study in Japanese children},
journal = {Pediatric Allergy and Immunology},
year = {2026},
volume = {37},
number = {10},
doi = {10.1111/pai.70489}
}
EUVIMED